Pulsed ElectRic FiEld Versus Cryoballoon for PAF
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 269 participants.
Also called NCT07100834
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 269 participants
- Registry
-
NCT07100834
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Belgium, Croatia, Greece, Italy, Poland
- Registry status
- Completed
Technical summary
Registry record NCT07100834. Randomized; single masking; primary purpose treatment. Start 2023-09-27 (actual); primary completion 2024-05-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Pulsed ElectRic FiEld Versus Cryoballoon for PAF
- Acronym
- PERFECT-PAF
- Condition
- Atril Fibrillation
- Condition
- Cardiac Arrhythmia
- Condition
- Paroxysmal Atrial Fibrillation (PAF)
- Intervention (Device)
- Single-Shot Pulsed Field Ablation (FARAPULSE™ Pulsed Field Ablation System)
- Intervention (Device)
- Single-Shot Cryoballoon Devices (Arctic Front Advance PRO, Medtronic Inc., Minneapolis, MN, USA; POLARx and POLARx FIT Balloon Catheter, Marlborough, MA, USA)
- Lead sponsor
- Universitair Ziekenhuis Brussel
Record details
- Record id
cardio:ct-nct07100834- Content hash
eaa991c97ab28dc9854ee0d21c7a253fcda8c1e4742c582bdcebc629824cbffd